Octamer
Pioneering pharmaceuticals for AIDS and cancer using advanced gene expression insights.
Pioneering pharmaceuticals for AIDS and cancer using advanced gene expression insights.
Octamer Inc. is a biotechnology startup founded in 1990 and based in Tiburon, California. The company's slogan "Pioneering pharmaceuticals for AIDS and cancer using advanced gene expression insights" reflects its focus on innovating pharmaceuticals to combat the replication of the AIDS virus and cancer cells. Octamer leverages advancements in the understanding of gene expression regulatory systems to inform its approach to rational drug design. The company received a $820.80K Venture Round investment on 18 September 2009. As of now, the investor for this round remains undisclosed. With its dedication to leveraging advanced gene expression insights for pharmaceutical innovation, Octamer Inc. stands as a notable player in the biotechnology industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $820.80K | - | 18 Sep 2009 |
No recent news or press coverage available for Octamer.
We care about your data, and we'd love to use cookies make your experience better.